European Journal of Cardiovascular Medicine

Background: Tuberculous pleural effusion represents a significant manifestation of extrapulmonary tuberculosis, with pleuritic chest pain being a common symptom that affects patient quality of life and treatment outcomes. Methods: This retrospective study analyzed 100 patients with tuberculous pleural effusion undergoing antitubercular treatment at a tertiary care teaching hospital. Data on demographic and clinical characteristics, treatment outcomes, and the prevalence of pleuritic chest pain were collected and analyzed. Results: The study found that 82% of patients presented with pleuritic chest pain, which significantly reduced to 8% by the end of treatment. The majority of patients were males (57%), with a mean age of 37.46 ± 14.2 years. Malnutrition was prevalent, with 44% of patients having a BMI of less than 18.5 kg/m^2. Fever (93%) and cough (72%) were the most common symptoms at presentation. Treatment outcomes were positive, with 94% of patients completing treatment.Conclusion: The significant reduction in pleuritic chest pain highlights the efficacy of antitubercular treatment. The study underscores the importance of addressing nutritional needs and monitoring for potential drug resistance, especially in patients with persistent symptoms. Future research should focus on the comprehensive care approach, including the role of adjunct therapies in managing TB pleural effusion.